Cyxone

Cyxone Join us on our journey! Cyxone has been listed on the Nasdaq First North Growth Market since June 7, 2016.

Cyxone is working on improving treatments for diseases such as rheumatoid arthritis, multiple sclerosis and virally induced acute respiratory disorders such as Covid 19. Cyxone is actively seeking investors to help us continue on our path towards creating highly effective treatments for rheumatoid arthritis, multiple sclerosis and virally induced acute respiratory disorders such as Covid 19 in con

venient administration forms. For more information about investing in Cyxone, visit - https://cyxone.com/en/investor-relations/

Adress

Adelgatan 21
Malmö
21122

Webbplats

Aviseringar

Var den första att veta och låt oss skicka ett mail när Cyxone postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Genvägar

Dela